During pregnancy, the placentae of ungulate mammals (e.g., cows, sheep, and pigs) convert glucose into fructose, which is the most abundant hexose sugar in fetal fluids and blood. However, the role of fructose, the most enigmatic component of carbohydrate metabolism in fetal-placental tissues, is largely ignored because it is not metabolized via the glycolytic pathway or the Krebs cycle as an energy source. Here we provided evidence for biological functions of fructose that affect proliferative behavior of the conceptus trophectoderm/chorion via activation of the Akt-TSC2-MTOR signaling cascade. The phosphorylation for activation of this cascade is mediated by Olinked glycosylation with UDP-N-acetylglucosamine, a primary product of the hexosamine biosynthesis pathway. These results reveal novel functional roles of fructose in promoting embryonic/fetal growth and development during pregnancy, and also provide new insight into understanding the relationship between excessive fructose intake and metabolic disorders.
INTRODUCTION
Fructose, due to its low cost and high production efficiencies, is used widely in the food-processing industry [1, 2] . During the past four decades, fructose intake by gestating women has increased significantly in those countries where the Western diet is prevalent [1, 2] . Epidemiological and animal studies have linked excessive intake of refined sugars (e.g., fructose-containing sugars: sucrose and high-fructose corn-syrup) during pregnancy with increased risk of developing obesity, insulin resistance, and type 2 diabetes in offspring in their adult lives [3] [4] [5] . These adverse metabolic effects associated with excessive intake of fructose intake have drawn attention from mainstream media and the scientific community with respect to periods of exposure (prenatal, postnatal, adolescent, and adulthood), dosage levels, and underlying mechanisms [6] [7] [8] . However, there are few well-controlled animal studies or human trials demonstrating potential beneficial or adverse impacts of fructose consumption on fetal development during any stage of pregnancy.
Domestic livestock species are invaluable animal models used extensively in biomedical research related to human and veterinary medicine [9] [10] [11] . Of particular interest, ewes and pigs are established animal models for studies of reproductive medicine and fetal origins of disease, such as intrauterine growth restriction [12] . During pregnancy, placentae of ungulates (i.e., pigs and ruminants) are fructogenic as glucose that is not metabolized immediately is converted into fructose by trophectoderm cells and stored in allantoic fluid [13] [14] [15] . In fact, fructose is the most abundant hexose sugar in fetal fluids of ungulates [16] [17] [18] [19] . In ewes, for example, the concentration of fructose is between 11.1 to 33.3 mM in allantoic fluid during pregnancy whereas the maximum concentration of glucose is only 1.1 mM [13] . Fructose is also present, but as a relatively minor sugar compared with glucose, in fetal blood and fetal fluids of humans and other mammals (e.g., dog, cat, guinea pig, rabbit, rat, and ferret) [14, 20, 21] . In general, high levels of fructose are found in the fetal fluids and blood of mammals having epitheliochorial and synepitheliochorial placentae [14] , such as pigs and sheep, which are invaluable animal models for studying the potential role of fructose during pregnancy. However, the role of fructose during pregnancy in ungulates is largely ignored because fructose is not metabolized via the glycolytic pathway or the Krebs cycle as an energy source.
Results of previous studies with pregnant ewes demonstrated that 1) injection of glucose into ewes caused a rapid elevation in glucose followed by a protracted increase in fructose in fetal blood, 2) the placenta is the site of conversion of glucose to fructose, 3) production of fructose by the placenta is independent of glucose concentration in maternal or fetal blood, and 4) glucose can move from the fetal-placental to the maternal circulation, whereas fructose derived from glucose in the conceptus is not transported into maternal blood [18, [22] [23] [24] . Thus, fructose is a sequestered hexose sugar in ungulates. Recent research in our laboratory with porcine trophectoderm cells demonstrated functional roles of fructose to induce cell proliferation and mRNA translation via stimulation of MTORC1 cell signaling, which may be mediated via hexosamine biosynthesis [25] . However, the underlying mechanism and biochemical intermediates responsible for the functional roles of fructose-activation of MTORC1 cell signaling and stimulation of cell proliferation-are not known. Thus, we conducted experiments to elucidate metabolic pathways involving fructose to gain insight into mechanisms whereby fructose affects the functions of ovine trophectoderm (oTr) cells.
MATERIALS AND METHODS
All experimental procedures in the current study were carried out in accordance with guidelines from the research committee and approved by the Institutional Biosafety Committee of Texas A&M University.
Cell Culture
An established mononuclear oTr primary cell line from Day 15 sheep conceptuses was developed, propagated, and used in the present in vitro studies as described previously [26] [27] [28] [29] [30] . One cell line (oTr1) that exhibits numerous properties of oTr cells in vivo, including production of interferon tau, which is the pregnancy recognition signal in ruminant species, was cultured in complete medium (CM). CM is Dulbecco modified Eagle medium/nutrient mixture F-12 (Gibco BRL) containing 10% fetal bovine serum (FBS) (Gibco BRL), 50 U/ml penicillin, 50 lg/ml streptomycin, 0.1 mM each for nutritionally nonessential amino acids, 1 mM sodium pyruvate, 2 mM glutamine, and 4 lg/ml insulin. The medium was replaced every 2 days. When cells in the dishes reached about 80% confluence, subcultures of cells were prepared at a ratio of 1:3, and frozen stocks of cells were preserved at each passage.
For the experiments, monolayer cultures of oTr1 cells (between passages 8 and 15) were grown in CM to 20%-30% confluence in 24-well plates (Costar 3524; Corning), T75 flask (Costar 430641; Corning), Lab-Tek II 4-well chamber slides (154534; Sigma-Aldrich), or 100 mm cell culture dishes (Costar 430167; Corning). Cells were serum-and insulin-starved for 24 h in customized medium, further deprived of glucose and fructose for an additional 6 h, and then treated with glucose, fructose, glucosamine, UDP-N-acetylglucosamine (UDP-GlcNAc) (U4375, CAS no. 91183-98-1; Sigma-Aldrich), azaserine, an inhibitor of glutamine-fructose-6-phosphate transaminase 1 (GFPT1) (A4142; Sigma-Aldrich), and/or alloxan, an inhibitor of O-linked N-acetylglucosamine transferase (OGT) (A7413; Sigma-Aldrich), at the indicated concentrations in basal medium (BM): glucose-and fructose-free customized medium containing 5% FBS and 1 ng/ml insulin. For each assay, the design was replicated in three independent experiments.
Proliferation Assay
The oTr1 cells were seeded (1 3 10 4 cells/0.4 ml/well) in a 24-well plate in CM until the monolayer reached up to 30% confluence, and then the cells were switched to serum-and insulin-free customized medium. After starvation for 24 h, cells were further deprived of serum, insulin, glucose, and fructose for an additional 6 h. Cells (n ¼ 3 wells per treatment) were then cultured in 400 ll BM at 0 min as a blank control, and then treated with glucose, fructose, UDPGlcNAc, glucosamine, azaserine, and/or alloxan at selected doses. The medium was changed every 2 days, and treated cells were maintained for 48 and 96 h. Cell numbers were determined as described previously [31] .
Adhesion Assay
The oTr1 cells were seeded (0.33 3 10 6 cells/5 ml/flask) in T25 flasks in CM until the monolayer reached up to 30% confluence, and then the cells were switched to serum-and insulin-free customized medium. After starvation for 24 h, cells were further deprived of serum, insulin, and UDP-GlcNAc, glucose, or fructose for an additional 24 h. Cells (n ¼ 3 flasks per treatment) were then cultured in 3 ml BM with or without: 1) 10 mM UDP-GlcNAc, 1 mM glucose, or UDP-GlcNAc plus glucose; or 2) 4 mM glucose or 4 mM fructose for 48 h of incubation. Cells from each flask in each treatment were then transferred (200 3 10 3 cells/0.4 ml BM/well) into the 24-well plate for the attachment process. After attachment for 20 min or 1 h (378C, 5% CO 2 ) in BM, nonadherent cells were removed by washing in PBS and wells were fixed in 10% vol/vol formalin in PBS. Cell numbers were determined as described in the aforementioned proliferation assay.
Analyses of Intracellular Glucosamine-6-Phosphate
Concentrations of glucosamine-6-phosphate (GlcN-6-P) were determined in oTr1 cell lysates as described previously [32] . Briefly, oTr1 cells (1 3 10 6 cells) were seeded in T75 flasks, maintained overnight (;16 h) in CM, and then switched to serum-and insulin-free customized medium. After serum and insulin starvation for 24 h followed by extra deprivation of glucose or fructose for an additional 6 h, cells (n ¼ 3 flasks/treatment) were subcultured in the absence or presence of glucose (4 mM) or fructose (4 mM) with or without azaserine (2 lM) in 10 ml BM. The BM was removed at the end of a 48-h culture period, and cell numbers determined using a hemocytometer. Cell pellets from each T75 flask were collected and then acidified with 200 ll of 1.5 M HClO 4 and neutralized with 100 ll of 2 M K 2 CO 3 . The neutralized extracts were used for analysis by a high performance liquid chromatography method involving precolumn derivatization with o-phthaldialdehyde [32] . The mobile phase was as follows: 86% solvent A (0.1 M sodium acetate, 0.5% tetrahydrofuran, 9% methanol, pH 7.2) and 14% solvent B (methanol) from 0 to 14 min; 100% solvent B from 14.1 to 18 min; and 86% solvent A and 14% Solvent B from 18.1 to 24.5 min. The retention time of 8.24 min for GlcN-6-P was determined using an authentic GlcN-6-P standard.
Analyses of Uptake of UDP-GlcNAc by oTr1 Cells
Uptake of UDP-GlcNAc was measured at 378C over a 5-min linear incubation period in 0.2 ml of customized medium (i.e., Dulbecco modified Eagle medium/nutrient mixture F-12 containing 5% FBS, 50 U/ml penicillin, 50 U/ml penicillin, 50 lg/ml streptomycin, 0.1 mM each for the nutritionally nonessential amino acids, 1 mM sodium pyruvate, 2 mM glutamine, and 4 lg/ ml insulin) supplemented with 0.1 mM UDP-GlcNAc as described previously [33] . The medium also contained [ 14 C] UDP-GlcNAc (0.5 lCi/ml) for determination of the uptake of UDP-GlcNAc; [ 3 H] inulin (0.5 lCi/ml) served as the extracellular marker for oTr1 cells. Incubation medium and cell suspensions were at 378C for 5 min before addition of cells (1 3 10 6 per 0.2 ml) to initiate measurement of uptake of [ 14 C] UDP-GlcNAc. After a 5-min incubation period, the incubation medium containing labeled UDP-GlcNAc and inulin were immediately mixed and transferred to a 1.5-ml microcentrifuge tube that contained 0.7 ml of a mixture of oil (bromododecane/dodecane, 20:1, v/v) overlaid on 0.2 ml of 1.5 M HClO 4 (acid layer). Cells were separated from the medium through the oil layer and into the acid layer during centrifugation (10 000 3 g, 1 min). The oil layer was washed three times with fresh PBS buffer, and the acid layer containing [
14 C] UDP-GlcNAc was counted for radioactivity in a Beckman liquid scintillation counter. The amounts of radioactivity of [ 14 C] UDP-GlcNAc in the acid layer after correction for the minimal contamination by the incubation medium were used to calculate the uptake of UDP-GlcNAc. All radioactive chemicals were purchased from American Radiolabeled Chemicals.
Quantitative Immunocytochemistry
The effects of glucose, fructose, and UDP-GlcNAc on phosphorylation of MTOR, TSC2, and Akt were determined by immunofluorescence microscopy as previously described [30] . The oTr1 cells were seeded (1 3 10 4 cells/0.4 ml/ well) onto Lab-Tek II 4-well chamber slides. After serum and insulin starvation for 24 h followed by additional deprivation of glucose and fructose for an extra 6 h, the cells were treated with: 1) glucose (4 mM) or fructose (4 mM) in BM with or without azaserine (2 lM) or 2) UDP-GlcNAc (10 mM) in BM. After 0.5, 1, 24, 48, and 96 h, cells were fixed with methanol at À208C for 10 min and rinsed with 0.02 M of PBS containing 0.3% Tween for 5 min. The cells were blocked in 5% normal goat serum for 2 h at room temperature, rinsed, and then an immunofluorescence double staining procedure with separate antibody incubations was performed. Briefly, the cells were probed with the first primary antibody against total MTOR (t-MTOR), t-TSC2, or t-Akt at a dilution of 1:100 overnight at 48C and then a first secondary antibody at a dilution of 1:250 for 4 h at 258C; cells were rinsed and incubated with a second primary antibody against phosphorylated MTOR (p-MTOR) (1:50), p-TSC2 (1:100), or p-Akt (1:50) overnight, a second secondary antibody for 4 h, and then rinsed in PBS containing 0.3% Tween and overlaid with Prolong Gold Antifade with 4 0 ,6-diamidiono-2-phenylindole. Images were captured using a Zeiss Axioplan 2 microscope with an Axiocan high-resolution camera and Axiovision 4 software (Carl Zeiss Microscopy). All parameters during image acquisition were the same. Signals were quantified by ImageJ software (version 1.47, National Institutes of Health) using standardized procedures. Information for all the antibodies is provided in Table 1 .
Morpholino Design
Morpholino antisense oligonucleotides (MAOs) were designed and synthesized by Gene Tools to directly inhibit translational initiation of OGT mRNA, the enzyme that mediates O-GlcNAcylation, and a MAO standard served as the MAO control. The MAO-OGT had the sequence 5 0 -TTGCC CACGG AAGAC GCCAT CTGGA-3 0 and targeted the starting codon of OGT WANG ET AL.
mRNA, whereas the MAO control had the sequence 5 0 -CCTCT TACCT CAGTT ACAAT TTATA-3 0 and targeted to a splice site mutant of Homo sapiens hemoglobin b-chain (HBB) gene (GenBank accession no. GU324922). All morpholinos were synthesized with a 3 0 -lissamine modification for convenient detection.
In Vitro Transfection Studies
The oTr1 cells were seeded (0.33 3 10 6 cells/5 ml/flask) in T25 flasks in CM until the monolayer reached up to 60% confluence, and then the cells were switched to serum-and insulin-free customized medium with or without 1) Endo-Porter aqueous delivery reagent (Gene Tools) (10 ll/ml medium) and 10 lM MAO-OGT or MAO control for cell transfection or 2) 1 mM alloxan to inhibit OGT. After 24 h of starvation and/or transfection, cells were further deprived of serum, insulin, and fructose for an additional 6 h. Cells (n ¼ 3 flasks per treatment) were then cultured in 5 ml medium for the following treatments: 1) BM as blank control, 2) 4 mM fructose, 3) 1 mM alloxan as inhibitor control, 4) 4 mM fructose plus 1 mM alloxan, 5) MAO standard as MAO control, 6) 4 mM fructose plus MAO control, 7) MAO-OGT, and 8) 4 mM fructose plus MAO-OGT. After 1 h of incubation with or without 4 mM fructose, cells were lysed and cell lysates were analyzed for expression of OGT protein and total protein O-GlcNAcylation as well as activation of MTOR, P70S6K, and 4EBP1 by Western blot employing antibodies against OGT, O-GlcNAc, t-MTOR, p-MTOR, t-P70S6K, p-P70S6K, t-4EBP1, and p-4EBP1 as previously described [34] (see Table 1 ). In addition, the aforementioned cell proliferation assay was performed after 48 h of incubation.
Western Blot Analyses
Whole-cell extracts and immunoblot assays were prepared and performed as described previously [34] . For alloxan inhibition studies, the oTr1 cells were seeded (1 3 10 6 cells/10 ml/dish) in 100 mm cell culture dishes in CM until the monolayer reached 60% confluence and then switched to serum-and insulin-free customized medium. After starvation for 24 h, cells were further deprived of serum, insulin, glucose, and fructose for an additional 6 h. Cells (n ¼ 3 wells per treatment) were then cultured in 10 ml BM containing glucose, fructose, or glucosamine with or without alloxan at selected doses for 1 and 24 h. For MAO transfection studies, the oTr1 cells were seeded (0.33 3 10 6 cells/5 ml/flask) in T25 flasks in CM until the monolayer reached 60% confluence, and then the cells were switched to serum-and insulin-free customized medium. Meanwhile, cells were transfected with 10 lM of MAO-OGT or MAO control during a 24-h serum-and insulin-starvation period, and then further deprived of serum, insulin and fructose for an additional 6 h. Transfected cells were then cultured in 5 ml BM with or without fructose for 1 h. After 1 or 24 h, cells were lysed for 30 min at 48C in 0.3 ml of a lysis buffer. Cell lysates were passed through a 26-gauge needle and clarified by centrifugation (21 000 3 g for 15 min at 48C). Protein concentration in the supernatant fluid was determined. Proteins were denatured, separated using SDS-PAGE (4% to 12% gradient gel at 150 V for 2.5-3 h), and transferred to a nitrocellulose membrane overnight (;16 h) at 20 V using the Bio-Rad Transblot. Membranes were blocked in 5% fat-free milk in Tris-Tween buffered saline (TBST), that is, 20 mM Tris/150 mM NaCl, pH 7.5, and 0.1% Tween-20, for 3 h and then incubated with primary antibody detecting OGT, O-GlcNAc, as well as total and phosphorylated MTOR, TSC2, Akt, P70S6K, and 4EBP1 at dilutions of 1:1000 at 48C overnight with gentle rocking. After washing three times with TBST, the membranes were incubated at room temperature for 2 h with secondary antibody (horseradish peroxidase-linked anti-rabbit or mouse immunoglobulin G) at dilution of 1:10 000. The membranes were then washed with TBST, followed by development using enhanced chemiluminescence detection (SuperSignal West Pico; Pierce) according to the manufacturer's instructions. As a loading control, rabbit or mouse anti-b-actin (ACTB) polyclonal immunoglobulin G was used after detecting the proteins on the blots. Multiple exposures of each Western blot were performed to ensure linearity of chemiluminescence signals. Western blots were quantified by measuring the intensity of light emitted from correctly sized bands under ultraviolet light using a ChemiDoc EQ system and Quantity One software (Bio-Rad). Information for all antibodies is listed in Table 1 .
Statistical Analysis
Normality of data and homogeneity of variance were tested using the Shapiro-Wilk test and Brown-Forsythe test, respectively, in SAS 8.1 (SAS Institute). Data were analyzed by least-squares one-way analysis of variance (ANOVA) as well as the Fisher least significant difference as post hoc analysis, with each well identified as an experimental unit. All analyses were performed using SAS. Data are expressed as means and SEM, and values of P , 0.05 were considered significant. 
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RESULTS
Glucose and Fructose Stimulate oTr1 Cell Proliferation That Requires GFPT1 Activity
We first investigated the effects of glucose and fructose on proliferation of oTr1 cells. After 48 and 96 h of culture, both glucose and fructose stimulated (P , 0.05) cell proliferation, with 4 mM being the optimal dose for each hexose sugar to exert maximum effects on cell proliferation by 1.7-(P , 0.01) and 1.4-fold (P , 0.05) for glucose (Fig. 1, A and B) as well as 1.6-(P , 0.01) and 1.4-fold (P , 0.05) for fructose (Fig. 1, C  and D) . However, treatment of oTr1 cells with both glucose and fructose did not have an additive or a synergistic effect (P . 0.10; Fig. 1, E and F) . Thus, fructose and glucose have equivalent biological effects to stimulate proliferation of oTr1 cells. To determine whether GFPT1 is an upstream regulator of glucose-and fructose-induced cell proliferation and a nutrient sensor in the hexosamine biosynthesis pathway, we used azaserine (an inhibitor of GFPT1) to assess whether GFPT1 is required for glucose and fructose to activate oTr1 cell proliferation. After 48 and 96 h of culture, azaserine inhibited (P , 0.05) the ability of both glucose and fructose to stimulate proliferation of oTr1 cells (Fig. 1, E and F) . In particular, the rate of oTr1 cell proliferation decreased (P , 0.01) by 19.5% and 26.1% with the addition of 2 lM azaserine compared with effects of glucose alone at 48 and 96 h, respectively, whereas cell proliferation was decreased (P , 0.01) 18.4% and 28.4% by azaserine as compared to effects of fructose alone at 48 and 96 h, respectively. In the presence of both fructose and glucose, azaserine inhibited (P , 0.01) proliferation of oTr1 cells by 24.6% and 30.4% at 48 and 96 h, respectively. These results indicate that the nutrient-sensing system in oTr1 cells is equally sensitive to fructose and glucose and requires GFPT1 activity for conversion of glucose-6-phosphate and fructose-6-phosphate to GlcN-6-P.
Glucose and Fructose Act Independently to Increase Concentrations of Intracellular GlcN-6-P
We next directly assessed the concentrations of intracellular GlcN-6-P, the precursor of UDP-GlcNAc, which is a product of the hexosamine biosynthesis pathway. As illustrated in Figure 1G , glucose and fructose increased (P , 0.05) intracellular concentrations of GlcN-6-P by 2.4-and 2.3-fold after 48 h of incubation, respectively, compared with the control (glucose-and fructose-free media). Inhibition of GFPT1 in oTr1 cells treated with glucose or fructose decreased (P , 0.05) the production of GlcN-6-P to basal control levels.
Glucose and Fructose Stimulate Proliferation of oTr1 Cells via GFPT1 Activity-Mediated Stimulation of the MTOR Cell Signaling Pathway
Next, we evaluated the abundance of t-MTOR and p-MTOR in oTr1 cells in short-(0.5 and 1 h) and long-term (24, 48, and
FIG. 1. Glucose (A and B)
and fructose (C and D) stimulate proliferation of oTr1 cells via GFPT1 activity (E and F) and increased intracellular concentration of glucosamine-6-phosphate (GlcN-6-P). The oTr1 cells were seeded at 25% confluence in wells and cultured with the indicated doses of glucose and fructose for 48 (A and C) and 96 h (B and D). In addition, the oTr cells pretreated for 2 h with or without 2 lM azaserine (GFPT1 inhibitor) were stimulated with 4 mM glucose and/or fructose for 48 (E) and 96 h (F). Cell numbers were determined after 48 and 96 h of incubation, and data are expressed as a percentage change relative to the nontreated controls (100%) at 0 min. Effects of glucose and fructose were dose dependent (P , 0.05), with different superscript letters denoting significant differences (P , 0.05). G) Fructose increased (P , 0.05) intracellular concentrations of GlcN-6-P at 48 h after treatment as did glucose. Inhibition of GFPT1 decreased (P , 0.01) GlcN-6-P production to basal levels similar to the control (glucose-and fructose-free). All quantitative data are presented as means with SEM, n ¼ 3. Different superscript letters denote significant differences (P , 0.05).
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96 h) cultures using quantitative immunocytochemical analyses ( Fig. 2 and Supplemental Fig. S1 ; Supplemental Data are available online at www.biolreprod.org). After 0.5, 1, 24, 48, and 96 h of incubation, p-MTOR was increased (P , 0.01) 3.7-, 4.2-, 3.3-, 2.1-, and 2.5-fold in glucose-treated cells and 3.1-, 4.4-, 3.8-, 2.3-, and 2.2-fold in fructose-treated cells as compared to BM control cells at each of the time points (Fig. 2 and Supplemental Fig. S1 ). When GFPT1 activity was FIG. 2. Glucose and fructose activate MTOR signaling pathway via increased phosphorylation of MTOR that is mediated by GFPT1 activity in oTr1 cells. After serum and insulin starvation for 24 h followed by an additional deprivation of glucose or fructose for 6 h (including 2 h pretreatment with or without 2 lM azaserine), oTr1 cells were treated with glucose (4 mM) or fructose (4 mM) in basal medium (BM). Quantitative immunocytochemical analyses demonstrated an increased abundance of p-MTOR in oTr1 cells treated with both glucose and fructose at 24 h, whereas inhibition of GFPT1 activity blocked the increased phosphorylation (A and C). Abundance of t-MTOR was not different among treatment groups at 24 h (A and B) . CTCF, corrected total cell fluorescence; a.u., arbitrary units. Width of field ¼ 220 lm. Data are presented as means and SEM, n ¼ 3. Different superscript letters denote significant differences (P , 0.05).
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inhibited by 2 lM azaserine, the effects of glucose and fructose on phosphorylation of MTOR were reduced (P , 0.01) by 62.9% and 72.5% at 0.5 h, 72.1% and 68.2% at 1 h, 68.5% and 69.8% at 24 h, 51.3% and 44.7% at 48 h, and 64.6% and 60.2%
at 96 h of incubation, respectively ( Fig. 2 and Supplemental  Fig. S1 ). However, t-MTOR in oTr1 cells was not affected significantly by either glucose or fructose alone (Fig. 2 and Supplemental Fig. S1 ).
FIG. 3.
Glucose and fructose activate MTOR via increased phosphorylation of TSC2 that is mediated by GFPT1 activity in oTr1 cells. After serum and insulin starvation for 24 h followed by additional deprivation of glucose or fructose for 6 h (including 2 h pretreatment with or without 2 lM azaserine), oTr1 cells were treated with glucose (4 mM) or fructose (4 mM) in basal medium (BM). Quantitative immunocytochemical analyses demonstrated increased abundance of p-TSC2 in oTr1 cells treated with both glucose and fructose at 24 h, whereas inhibition of GFPT1 activity blocked such effects (A and C). Abundance of t-TSC2 was not different among treatment groups at 24 h (A and B) . CTCF, corrected total cell fluorescence; a.u., arbitrary units. Width of field ¼ 220 lm. Data are presented as means and SEM, n ¼ 3. Different superscript letters denote significant differences (P , 0.05).
Glucose and Fructose Activate the MTOR Signaling Pathway via Increased Phosphorylation of TSC2 That Is Dependent on GFPT1 Activity in oTr1 Cells
We further determined the abundance of t-TSC2 and p-TSC2 in oTr1 cells in short-(0.5 and 1 h) and long-term (24, 48 , and 96 h) cultures using quantitative immunocytochemical analyses ( Fig. 3 and Supplemental Fig. S2 ). After 0.5, 1, 24, 48, and 96 h of incubation, p-TSC2 increased (P , 0.01) 3.2-, 2.2-, 2.6-, 2.6-, and 2.6-fold in glucose-treated cells and 3.0-, 2.1-, 3.4-, 3.1-, and 2.5-fold in fructose-treated cells as compared to BM control cells at each of the time points, respectively ( Fig. 3 and Supplemental Fig. S2 ). When 2 lM azaserine was added to the culture medium, the effects of glucose and fructose on phosphorylation of TSC2 were reduced (P , 0.01) by 63.7% and 69.8% at 0.5 h, 51.5% and 53.1% at 1 h, 62.4% and 66.6% at 24 h, 61.6% and 69.8% at 48 h, and 61.2% and 66.9% at 96 h of culture, respectively ( Fig. 3 and Supplemental Fig. S2 ). Abundance of t-TSC2 in oTr1 cells was not affected significantly by glucose or fructose alone except at 96 h culture where it increased (P , 0.05) 1.5-and 1.6-fold in the glucose-or fructose-treated cells, respectively ( Fig. 3 and Supplemental Fig. S2 ). In the presence of 2 lM azaserine, stimulatory effects of glucose and fructose on t-TSC2 were reduced (P , 0.01) to basal levels for control (glucose-and fructose-free) cultures.
UDP-GlcNAc Stimulates oTr1 Cell Proliferation
In order to verify that glucose-and fructose-induced proliferation of oTr1 cells involves UDP-GlcNAc, we investigated the direct effects of UDP-GlcNAc on proliferation of oTr1 cells. Meanwhile, the uptake of UDP-GlcNAc by oTr1 cells was 2.2 6 0.2 pmol/min per 10 6 cells, which was measured as described previously [33] . After 48 and 96 h of culture, UDP-GlcNAc stimulated (P , 0.05) proliferation of oTr1 cells in the absence of or at a low dose (1 mM) of glucose, with 10 mM UDP-GlcNAc being the optimal dose for maximum stimulation of cell proliferation by 1.5-and 1.3-fold (P , 0.01) in the absence of glucose as well as 1.5-and 1.4-fold (P , 0.01) in the presence of 1 mM glucose (Fig. 4, A  and B) . However, such proliferative effects of UDP-GlcNAc were not detected (P . 0.01) once the concentration of glucose reached 4 mM after 96 h of culture (Fig. 4) . These results indicate that UDP-GlcNAc stimulates oTr1 cell proliferation.
UDP-GlcNAc Activates the MTOR Signaling Pathway via Increased Phosphorylation of the Akt-TSC2-MTOR Signaling Cascade in oTr1 Cells
We further determined how UDP-GlcNAc affects the abundance of total and phosphorylated MTOR ( Fig. 5 and Supplemental Fig. S3 ), TSC2 ( Fig. 6 and Supplemental Fig.  S4 ), and Akt ( Fig. 7 and Supplemental Fig. S5 ) in oTr1 cells in short-(0.5 and 1 h) and long-term (24, 48 , and 96 h) cultures using quantitative immunocytochemical analyses. After 0.5, 1, 24, 48, and 96 h of incubation, p-MTOR increased 2.6-(P , 0.01), 2.1-(P , 0.0001), 2.6-(P , 0.0001), 2.9-(P , 0.0001), and 2.3-fold (P , 0.0001) in UDP-GlcNAc-treated cells as compared to BM control cells, respectively (Fig. 5 , A and C, and Supplemental Fig. S3 , A and C), whereas p-TSC2 increased 2.6-(P , 0.05), 3.2-(P , 0.001), 3.7-(P , 0.0001), 3.0-(P , 0.0001), and 4.0-fold (P , 0.0001) in UDPGlcNAc-treated cells as compared to control cells, respectively (Fig. 6 , A and C, and Supplemental Fig. S4, A and C) . However, no differences in the abundance of p-Akt between UDP-GlcNAc and control cells were detected (P . 0.05) after the short-term (0.5 and 1 h) incubation (Fig. 7 , A and C, and Supplemental Fig. S5, A and C) . However, after 24, 48, and 96 h of incubation, p-Akt increased 3.3-, 2.5-, and 1.9-fold in UDP-GlcNAc-treated cells as compared to BM control cells, respectively (Fig. 7 , A and C, and Supplemental Fig. S5 , A and C). Expression of t-MTOR (Fig. 5, A and B, and Supplemental Fig. S3, A and B) , t-TSC2 (Fig. 6, A and B, and Supplemental Fig. S4, A and B) , and t-Akt (Fig. 7, A and B, and Supplemental Fig. S5 , A and B) in oTr1 cells were not affected significantly by UDP-GlcNAc except at 96-h culture when p-TSC2 increased (P , 0.0001) 2.1-fold in UPDGlcNAc-treated cells (Fig. 6, A . The oTr1 cells were seeded at 25% confluence in wells. After being serum-and insulin-starved for 24 h followed by being deprived of glucose for an additional 6 h, cells were cultured with the indicated doses of UDP-GlcNAc in the presence of different doses of glucose (0, 1, or 4 mM). Cell numbers were determined after 48 and 96 h of incubation, and data expressed as percentage change relative to the nontreated control cells (100%) at 0 min. Dosage effects of UDP-GlcNAc were detected (P , 0.05) when glucose was at 0 or 1 mM at 96 h and at 0, 1, and 4 mM at 48 h. Different superscript letters denote significant differences (P , 0.05). All quantitative data are presented as means and SEM, n ¼ 3.
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UDP-GlcNAc, Glucose, and Fructose Stimulate Adhesion of oTr1 Cells
We performed cell adhesion assays to the evaluate effects of UDP-GlcNAc, glucose, and fructose on oTr1 cell attachment, which would recapitulate the adhesive behavior of conceptus trophectoderm to uterine luminal epithelium during implantation in pregnant ewes. After a 1-h attachment period, cells pretreated with UDP-GlcNAc for 48 h exhibited increased adhesiveness by 1.2-fold (P , 0.01) as compared to cells preincubated within BM only (Fig. 8A) . When the culture system contained 1 mM glucose, UDP-GlcNAc also stimulated cell adhesion, but to a lesser extent (1.1-fold, P , 0.05; Fig.  S1A ). Moreover, preincubation with glucose or fructose for 48 h stimulated cell adhesion by 1.1-fold (P , 0.05) for both sugars after 1-h attachment and 1.5-fold (P , 0.05) for both sugars after a 20 min attachment period (Fig. 8, B and C) . These results indicate that UDP-GlcNAc, glucose, and fructose can stimulate adhesion of oTr1 cells.
Glucose, Fructose, and Glucosamine Stimulate Proliferation of oTr1 Cells via OGT Activity That Mediates O-GlcNAcylation
To determine whether the hexosamine biosynthesis pathway-related O-GlcNAcylation is involved in the regulation of glucose-and fructose-induced cell proliferation, we used alloxan, the inhibitor of OGT, to assess whether OGT is required for glucose and fructose to induce proliferation of oTr1 cells. Glucosamine at the optimal dose of 0.5 mM (Fig. 9 , A and B) was used because it is the common precursor of GlcN-6-P, the product of the first step in hexosamine biosynthesis. After 48 and 96 h of culture, proliferation of oTr1 cells increased 1.8-and 2.1-fold (P , 0.01) in glucosetreated cells and 1.7-and 2.1-fold (P , 0.01) in fructosetreated cells, whereas glucosamine stimulated cell (P , 0.05) proliferation by 1.2-and 1.3-fold at 48 and 96 h, respectively (Fig. 9, C and D) .
Alloxan inhibited (P , 0.05) glucose, fructose, and glucosamine effects to stimulate proliferation of oTr1 cells (Fig. 9, C and D) . In particular, the rate of oTr1 cell proliferation decreased (P , 0.01) by 31.6% and 36.9% with the addition of 0.1 and 1 mM alloxan, respectively, compared with effects of glucose alone at 48 h and decreased by 16.8% (P , 0.05) and 40.6% (P , 0.01) at 96 h, respectively. Likewise, for fructose treatments, oTr1 cell proliferation decreased (P , 0.01) by 21.1% and 30.1% with the addition of 0.1 and 1 mM alloxan, respectively, as compared with effects of fructose alone at 48 h and decreased by 16.6% (P , 0.05) and 39.4% (P , 0.01) at 96 h, respectively. In the presence of glucosamine, alloxan inhibited (P , 0.05) proliferation of oTr1 cells by 14.8% (0.1 mM alloxan) and 24.5% (1 mM alloxan) at 48 h and by 21.3% (1 mM alloxan) at 96 h. These results indicate that glucose-, fructose-, and glucosamine-induced stimulation of oTr1 cell proliferation involve OGT-mediated O-GlcNAcylation. 
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Glucose, Fructose, and Glucosamine Increase OGT Expression and Protein O-GlcNAcylation, and Alloxan Inhibits Those Effects
To validate whether glucose-, fructose-, and glucosamineinduced proliferation of oTr1 cells involves OGT-mediated OGlcNAcylation, Western blot analyses determined the abundance of OGT protein and total protein O-GlcNAcylation in oTr1 cells treated with glucose, fructose, or glucosamine in the absence or presence of alloxan (Fig. 10) . After 24 h of incubation, glucose, fructose, and glucosamine increased OGT expression by 1.8-. 1.6-, and 3.2-fold (P , 0.05), respectively, as well as O-GlcNAcylation by 2.2-, 2.0-, and 3.4-fold (P , 0.05), respectively, as compared to the BM control. However, in the presence of 1 mM alloxan, OGT expression was decreased by 65.5%, 59.0%, and 74.4% (P , 0.001) whereas protein O-GlcNAcylation decreased by 59.1%, 60.2%, and 77.0% (P , 0.0001) in glucose-, fructose-, and glucosaminetreated cells, respectively, as compared to control cells. Moreover, no differences (P . 0.05) were observed in OGT expression and protein O-GlcNAcylation between the BM only and all other alloxan-containing cell cultures.
Glucose, Fructose, and Glucosamine Activate the Akt-TSC2-MTOR Signaling Cascade via O-GlcNAcylationMediated Phosphorylation
To further test the hypothesis that MTOR cell signaling in response to glucose, fructose, and glucosamine is mediated by hexosamine-associated O-GlcNAcylation, we used alloxan to determine whether OGT is required for glucose, fructose, and glucosamine to activate the Akt-TSC2-MTOR signaling cascade. Western blot analyses of whole oTr1 cell extracts revealed that glucose increased p-MTOR, p-TSC2, and p-Akt by 1.5-(P , 0.05), 1.6-(P , 0.05), and 3.7-fold (P , 0.01) at 1 h and by 5.4-(P , 0.01), 2.3-(P , 0.05), and 5.3-fold (P , 0.01) at 24 h, respectively, compared with the respective control cells (Fig. 11) . Likewise, fructose increased p-MTOR, p-TSC2, and p-Akt by 2.1-(P , 0.01), 2.6-(P , 0.01), and 4.2-fold (P , 0.05) at 1 h and by 6.6-(P , 0.01), 2.0-(P , 0.01), and 8.0-fold (P , 0.01) at 24 h, respectively (Fig. 11) . In the presence of glucosamine, the abundance of p-MTOR, p-TSC2, and p-Akt increased by 1.5-(P , 0.05), 2.9-(P , 0.01), and 5.6-fold (P , 0.01) at 1 h whereas they increased by 1.7-(P , 0.05), 1.3-(P , 0.05), and 2.1-fold (P , 0.01) at 24 h, respectively (Fig. 11) .
The presence of 1 mM alloxan in culture medium reduced (P , 0.05) the ability of glucose, fructose, and glucosamine to increase the phosphorylation of MTOR, TSC2, and Akt in oTr1 cells (Fig. 11) . In particular, p-MTOR, p-TSC2, and p-Akt abundances decreased 31.2%, 37.7%, and 49.8% at 1 h and 8 . UDP-GlcNAc, glucose, and fructose stimulate adhesion of oTr1 cells. The oTr1 cells were predeprived of serum and insulin for 24 h followed by further deprivation of UDP-GlcNAc, glucose, or fructose for an additional 24 h in T25 flasks prior to treatment: (A) BM control and 10 mM UDP-GlcNAc,63.5%, 38.8%, and 66.6% at 24 h, respectively, with the addition of 1 mM alloxan compared with effects of glucose alone. The effects of fructose on the abundance of p-MTOR, p-TSC2, and p-Akt were decreased by 58.8%, 45.4%, and 48.6% at 1 h and 79.7%, 53.1%, and 68.8% at 24 h, respectively, in the presence of 1 mM alloxan. Alloxan also decreased the abundances of p-MTOR, p-TSC2, and p-Akt by 40.5%, 53.4%, and 42.7% at 1 h and 45.7%, 24.2%, and 77.5% at 24 h, respectively, in the glucosamine-treated oTr1 cells. These results indicate that glucose-, fructose-, and glucosamineinduced phosphorylation of components of the MTOR signaling cascade are mediated via O-GlcNAcylation.
Knockdown of OGT mRNA Translation Decreases Proliferation of oTr1 Cells and Reduces O-GlcNAcylationMediated Phosphorylation of MTOR Cell Signaling Cascade
To further validate the results from alloxan experiments whereby fructose-activated MTOR cell signaling is mediated FIG. 9 . Glucose, fructose, and glucosamine stimulate oTr1 cell proliferation via O-linked N-acetylglucosamine transferase (OGT)-mediated OGlcNAcylation. A and B) Dose-dependent effects of glucosamine on cell proliferation of oTr1 cells at 48 and 96 h. C and D) The oTr1 cells underwent serum and insulin starvation for 24 h, followed by additional deprivation of glucose, fructose, or glucosamine for 6 h, and then were cultured with glucose (4 mM), fructose (4 mM), or glucosamine (0.5 mM) in the presence of alloxan (0, 0.1, or 1 mM). Cell numbers were determined after 48 or 96 h of incubation. Data are expressed as a percentage change relative to the nontreated controls (100%) at 0 min. Effects of glucosamine dosage were significant (P , 0.05) as noted by different superscript letters; effects of alloxan dosage were also significant (P , 0.05), and different superscript letters denote significant (P , 0.05) differences among treatment groups. All quantitative data are presented as means and SEM, n ¼ 3.
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by hexosamine-associated O-GlcNAcylation, knockdown of OGT mRNA translation in oTr1 cells was performed using MAOs. We first evaluated the efficiency for MAO delivery after 24 h of incubation by immunofluorescence microscopy (Fig. 12A) . The orange colored 3 0 -lissamine tag in MAOs confirmed MAO uptake by oTr1 cells. Next, we used 4 mM fructose combined with 1 mM alloxan, 10 lM MAO control (i.e., MAO standard), or 10 lM MAO-OGT to validate D-F) . The oTr1 cells were serum-and insulin-starved for 24 h, then deprived of glucose, fructose, or glucosamine for 6 h, and then treated with glucose (4 mM), fructose (4 mM), or glucosamine (0.5 mM) in the presence or absence of alloxan (1 mM). Blots were imaged to calculate the normalized values as abundance of phosphorylated protein relative to total protein. *P , 0.05, **P , 0.01, ***P , 0.001, and ****P , 0.0001 versus the respective control cells.
#, §,} denote significant (P , 0.05) differences compared with the BM control group. Data are presented as means and SEM, n ¼ 3. whether OGT is required for fructose to induce proliferation of oTr1 cells. After 48 h of culture, proliferation of oTr1 cells increased 1.8-fold (P , 0.0001) in fructose-treated cells, but this effect was inhibited (P , 0.0001) when alloxan was added (Fig. 12B) . Likewise, proliferation of oTr1 cells increased 1.9-fold (P , 0.0001) in oTr1 cells transfected with MAO control for 24 h and then treated with fructose for 48 h; however, cell proliferation was inhibited (P , 0.0001) when oTr1 cells were transfected with MAO-OGT for 24 h and then treated with fructose for 48 h (Fig. 12B) . Furthermore, Western blot analyses confirmed knockdown of OGT translation, abundance of total protein O-GlcNAcylation, as well as total and phosphorylated MTOR, P70S6K, and 4EBP1 in oTr1 cells treated with fructose combined with alloxan, MAO control, or MAO-OGT (Fig. 12, C and D) . After 1 h of incubation, OGT expression and abundance of total protein O-GlcNAcylation was decreased by 67.7% and 57.9%, respectively, in cells treated with fructose plus alloxan as compared to treatment with fructose alone. Similarly, OGT expression and abundance of total protein O-GlcNAcylation decreased by 81.6% and 81.3%, respectively, in cells transfected with MAO-OGT and then treated with fructose as compared to cells transfected with MAO control and then treated with fructose. In the same comparisons, alloxan inhibited phosphorylation of MTOR, P70S6K, and 4EBP1 by 50.1%, 71.6%, and 48%, respectively, in the presence of 4 mM fructose, whereas MAO-OGT decreased phosphorylation of MTOR, P70S6K, and 4EBP1 by 47.3%, 60.2%, and 61.1%, respectively, after 1 h of incubation with 4 mM fructose. These results indicate that fructose-induced phosphorylation of components of the MTOR signaling cascade is mediated via O-GlcNAcylation.
DISCUSSION
Fructose is the primary sugar in fetal fluids and blood of ungulates during pregnancy [13] [14] [15] [16] [17] [18] [19] . However, fructose is not metabolized via the glycolytic pathway in the placenta or fetus [35] [36] [37] [38] , unlike humans where fructose production is a continuous process from fetus to newborn at 48 h after birth to support lipid synthesis [39] ; other results, however, indicate that production of fructose by the human placenta is limited during the first trimester [20] . The rapid disappearance of fructose from fetal blood within 24 h after birth of ungulates indicates that neonatal piglets do not utilize fructose as an energy source or for any other major metabolic pathway [40] [41] [42] . Thus, fructose is a hexose sugar with unique roles in the ungulate conceptus during pregnancy. However, the roles of fructose within the pregnant uterus of ungulates such as sheep and pigs have been largely ignored by researchers focused on mechanisms responsible for intrauterine growth restriction and subsequent adult onset of metabolic disease. The presence of high concentrations of fructose (11 to 33 mM) compared to glucose (1 mM) during pregnancy may prevent glucose toxicity while allowing glucose to be spared for metabolism to produce energy, while fructose is used via other pathways such as the hexosamine pathway. Investigation into the functional roles of fructose during pregnancy of ungulates is imperative to understand its roles in the production of healthy offspring in the livestock industry, but also to help clinicians, dieticians, and animal scientists understand the relationship between fructose and metabolic disorders in human and veterinary medicine.
Results of this study provide evidence for key roles of fructose in cellular functions that are equivalent to those of glucose in activating mechanisms of actions via integrated cell signaling pathways affecting proliferation of oTr1 cells. The results support our hypothesis that fructose and glucose can be metabolized via the nonoxidative hexosamine biosynthesis pathway to GlcN-6-P by GFPT1, increase O-GlcNAcylation of cellular proteins/enzymes by OGT, and then increase phosphorylation of the Akt-TSC2-MTOR cell signaling cascade, thereby stimulating proliferation of oTr cells.
First, fructose and glucose each exert maximum effects on proliferation of oTr1 cells at 4 mM (Fig. 1A-D) , which indicates their equivalency in stimulating oTr1 cell proliferation. Given that the concentrations of fructose (11.1-33.3 mM) are much higher than glucose (0.6-1.1 mM) in ovine fetal fluids and blood, the results of the present study clearly indicate that fructose rather than glucose plays vital roles in the development of the conceptus (embryo/fetus and its associated placenta). Furthermore, fructose-and glucose-induced cell proliferation is dependent on GFPT1 activity (Fig. 1, E and F) , and both fructose and glucose increase the production of GlcN-6-P (Fig. 1G) . GFPT1 is the first and rate-limiting enzyme that converts fructose-6-phosphate to GlcN-6-P, thereby controlling the flux of hexose sugar (fructose or glucose) into the hexosamine pathway. The results of the present study indicate a novel, key role for fructose (the most enigmatic hexose sugar in carbohydrate metabolism by the ungulate conceptus) to stimulate cell proliferation through actions mediated via the hexosamine biosynthesis pathway.
MTOR, a serine/threonine kinase, is the catalytic subunit of two structurally distinct complexes: MTOR complex 1 (MTORC1) and complex 2 (MTORC2). In general, MTORC1 cell signaling relays signals stimulated by nutrients such as amino acids and mitogens to stimulate cell proliferation, differentiation, and gene expression [25] [26] [27] [43] [44] [45] [46] . Tuberous sclerosis complex 2 (TSC2) is a GTPase activating protein (GAP) that stimulates GTPase activity of the small GTPase Rheb [47, 48] . Because Rheb in its GTP-bound form is an activator of MTORC1, TSC2 in complex with TSC1 is inhibitory to the MTORC1 signaling cascade, and phosphorylation of TSC2 removes that inhibition. In the present study, both fructose and glucose increased phosphorylation of TSC2 and MTOR in oTr1 cells, and such activation of the signaling cascade was completely abrogated by azaserine, the inhibitor of GFPT1 activity. These results indicate that fructose, like glucose, activates the MTOR signaling cascade [25, [49] [50] [51] [52] and, therefore, stimulates proliferation of oTr1 cells via the hexosamine biosynthesis pathway.
The pathway for hexosamine biosynthesis yields UDPGlcNAc that is used for 1) cytosolic and Golgi-mediated Olinked glycosylation (O-GlcNAcylation) of proteins and 2) formation of glycosylphosphatidylinositol anchors that tether proteins to the outer plasma membrane. In particular, OGlcNAcylation is the process whereby b-D-N-acetylglucosamine is added to serine or threonine residues of proteins, and OGT is the catalytic enzyme required for this process. Therefore, cells were directly treated with UDP-GlcNAc in order to determine its effects on the function (proliferation and adhesion) of oTr1 cells as well as activation of the Akt-TSC2-MTOR signaling cascade. As a product of metabolism of glucose, fructose, and glutamine via the hexosamine biosynthesis pathway, UDP-GlcNAc can activate the Akt-TSC2-MTOR signaling cascade (Figs. 5-7 and Supplemental Figs. S3-S5) and, therefore, enhance proliferation and adhesion of oTr1 cells (Figs. 4 and 8A) . Further investigation revealed that glucose and fructose were equally capable of inducing cell adhesion (Fig. 8, B and C) , which is beneficial for implantation and placentation during pregnancy. Interestingly, UDPGlcNAc stimulated proliferation of oTr1 cells in a dosedependent manner when the culture medium was glucose-free or had a low amount of glucose (1 mM). However, when the concentration of glucose reached 4 mM in the culture medium, UDP-GlcNAc-induced cell proliferation was less significant at 48 h and was not observed at 96 h. These results suggest that physiological level of glucose and glutamine, the precursors of UDP-GlcNAc, are able to replace the effects of UDP-GlcNAc on cell behavior. In the current study, fructose, glucose, or glucosamine served as the common substrate for de novo synthesis of UDP-GlcNAc, thereby stimulating oTr1 cell proliferation. Alloxan, an inhibitor of OGT activity, attenuated the stimulatory effects of fructose, glucose, and glucosamine on cell proliferation, which strongly supports our hypothesis that fructose-, glucose-, and glucosamine-induced cell proliferation is regulated by O-GlcNAcylation.
We next asked the question whether there is crosstalk between O-GlcNAcylation and phosphorylation of proteins in oTr1 cells because previous studies indicated that interactions (competition or cooperation) between O-GlcNAcylation and phosphorylation is tissue-specific [53] [54] [55] . Using Western blot analyses to detect phosphorylated Akt, TSC2, and MTOR in the presence or absence of an OGT inhibitor, we found that fructose, glucose, and glucosamine increased the phosphorylation of Akt, TSC2, and MTOR whereas the OGT inhibitor abrogated such phosphorylation. These results indicate crosstalk between O-GlcNAcylation and phosphorylation of proteins in oTr1 cells. Particularly, O-GlcNAcylation cooperatively activates the Akt-TSC2-MTOR signaling cascade by increasing their state of phosphorylation.
To further validate that fructose-induced cell proliferation and activation of the MTOR cell signaling cascade is mediated by hexosamine-associated O-GlcNAcylation, knockdown of translation of OGT mRNA in oTr1 cells was performed by using MAOs (Fig. 12) . Similar to inhibition of OGT by alloxan, knockdown of OGT by MAO-OGT in oTr1 cells resulted in significant decreases in fructose-induced total protein O-GlcNAcylation and cell proliferation. Moreover, using Western blot analyses to detect total and phosphorylated MTOR and its downstream effectors, that is, P70S6K and 4EBP1, we found that fructose induced phosphorylation of MTOR, P70S6K, and 4EBP1, but such increases in phosphorylation were significantly abrogated in oTr1 cells with knockdown of OGT by MAO-OGT. Again, these results strongly support our hypothesis that fructose-induced cell proliferation and activation of MTOR cell signaling is regulated by O-GlcNAcylation.
In summary, fructose, the most abundant hexose sugar in fetal fluid and blood of ungulates, is equivalent to glucose in stimulating proliferation and mRNA translation of oTr1 cells via activation of the Akt-TSC2-MTOR signaling cascade (Fig.  13) . The phosphorylation for activation of this cascade is mediated by O-GlcNAcylation from UDP-GlcNAc, a primary product of the hexosamine biosynthesis pathway (Fig. 13) . In addition, metabolism of fructose via the hexosamine pathway has a sparing effect on glucose, which can then be used for ATP generation via glycolysis or Krebs cycle during pregnancy. These findings reveal the functional roles of fructose in promoting embryonic/fetal growth and development during pregnancy and also provide insights into potential relationships whereby between excessive fructose intake leads to metabolic disorders of interest in human and veterinary medicine.
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